Every Breath Matters. So Does Your Treatment Plan.
A lung cancer diagnosis carries enormous weight. Dr. Bedi cuts through uncertainty with clear answers, global-standard protocols, and genuine compassion.
Understanding Lung Cancer
Lung cancer begins when cells in the lungs grow uncontrollably. It's broadly classified into non-small cell (NSCLC) and small cell (SCLC) types. Risk factors include smoking, air pollution, and family history. Breakthroughs in immunotherapy and molecular profiling have transformed outcomes over the past decade.
Signs That Shouldn't Be Ignored
How Dr. Bedi Treats Lung Cancer
Dr. Bedi uses a precision-first approach: thorough profiling before any treatment, because the right diagnosis leads to the right therapy.
Molecular Profiling
Genetic testing identifies mutations (EGFR, ALK, ROS1, PD-L1) that determine which therapies work best for your exact cancer.
Immunotherapy
Checkpoint inhibitors help your immune system recognise and destroy cancer cells — with remarkable long-term responses for eligible patients.
Targeted Therapy
For driver-mutation cancers, oral medications control growth with fewer side effects than traditional chemo.
Chemotherapy
Platinum-based regimens remain highly effective for specific subtypes — especially when combined with immunotherapy.
A Note from Dr. Bedi
Lung cancer treatment has changed more in the last ten years than in the previous fifty. I've seen patients told there were no options go on to live years of meaningful life. Please don't lose hope before we've talked.
Questions Patients Often Ask
Can late-stage lung cancer be treated?
Yes. Immunotherapy and targeted therapy can extend life significantly and maintain quality — the key is matching the right treatment to the right patient.
I've never smoked — can I get lung cancer?
Around 15–20% of lung cancers occur in never-smokers. Air pollution, radon, secondhand smoke, and genetics are all factors.
What is molecular profiling?
It analyses your tumour's DNA for specific mutations, allowing Dr. Bedi to choose precisely targeted therapies rather than broad-spectrum approaches.
How has immunotherapy changed outcomes?
Immunotherapy has transformed survival for many patients. Some with advanced disease achieve durable responses lasting years.
Other Conditions We Treat
Ready to Take the Next Step?
Dr. Bedi and his team are here to listen, answer your questions, and build a path forward — together.